This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
10/08/15 - 12:52:12 PM ET (BATS BZX Real-time Price)
Div Yield: --
ACHN Day's Range
ACHN 52 Week Range
ACHN Business Summary
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.View ACHN key stats
Achillion Pharmaceuticals Inc - ACHN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Achillion Pharmaceuticals Inc as a
Sell with a ratings score of D.
Report Snippet: We rate ACHILLION PHARMACEUTICALS (ACHN) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.